share_log

4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

4:持股變動聲明-高管 Philibert Robert
美股SEC公告 ·  2024/09/11 05:24

牛牛AI助理已提取核心訊息

On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.
On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席醫療官Robert Philibert完成了兩筆共計34,075股普通股的購買交易。第一筆交易涉及以每股$0.287的價格收購了26,615股,而第二筆交易則以每股$0.2848的價格購入了7,460股。在這些交易之後,Philibert在該公司的總間接有利擁有股份達到了1,683,867股。這兩次收購都是在公開市場上完成的。
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席醫療官Robert Philibert完成了兩筆共計34,075股普通股的購買交易。第一筆交易涉及以每股$0.287的價格收購了26,615股,而第二筆交易則以每股$0.2848的價格購入了7,460股。在這些交易之後,Philibert在該公司的總間接有利擁有股份達到了1,683,867股。這兩次收購都是在公開市場上完成的。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。